You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Irinotecan failure

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ewing Sarcoma Trial in Beijing (Vincristine, Temozolomide)

Recruiting
  • Ewing Sarcoma
  • Beijing, Beijing, China
    Peking University People's Hospital
Oct 31, 2022

Metastatic Colorectal Cancer (mCRC) Trial in France (Regorafenib, Irinotecan)

Recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • Nice, Alpes-Maritimes, France
  • +10 more
Jan 16, 2023

Metastatic Colorectal Cancer Trial (trifluridine/tipiracil + XB2001, trifluridine/tipiracil + )

Not yet recruiting
  • Metastatic Colorectal Cancer
  • trifluridine/tipiracil + XB2001
  • trifluridine/tipiracil + placebo
  • (no location specified)
Jan 15, 2022

Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based

Active, not recruiting
  • Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy
  • Irinotecan liposome、5-Fluorouracil、Leucovorin
  • Placebo、5-Fluorouracil、Leucovorin
  • Nanjing, Jiangsu, China
    Qinhuai Medical Area, General Hospital of PLA Eastern Theater Co
Sep 29, 2021

Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Madrid, Spain
    Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
Oct 10, 2022

Advanced Colorectal Cancer Trial in Seoul (Cetuximab, irinotecan)

Completed
  • Advanced Colorectal Cancer
  • Cetuximab, irinotecan
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 17, 2021

Esophageal Squamous Cell Carcinoma Trial in Beijing (IBI308, paclitaxel/ irinotecan)

Completed
Has Results
  • Esophageal Squamous Cell Carcinoma
  • IBI308
  • paclitaxel/ irinotecan
  • Beijing, Beijing, China
    The Fifth Medical Center of PLA Ceneral Hospital
Jan 17, 2021

Ewing Sarcoma, Rhabdomyosarcoma Trial in Boston, Memphis (Olaparib, Temozolomide, Irinotecan)

Recruiting
  • Ewing Sarcoma
  • Rhabdomyosarcoma
  • Boston, Massachusetts
  • +4 more
Oct 27, 2021

Biliary Tract Cancer Trial in Busan (5-Fluorouracil, Leucovorin, Irinotecan)

Completed
  • Biliary Tract Cancer
  • Busan, Korea, Republic of
    Dong-A University Hospital
Feb 2, 2021

Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

Not yet recruiting
  • Rhabdomyosarcoma
  • Palo Alto, California
  • +2 more
Aug 27, 2023

Locally Advanced Unresectable Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Metastatic

Withdrawn
  • Locally Advanced Unresectable Gastric Adenocarcinoma
  • +5 more
  • Liposomal Irinotecan
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Mar 25, 2020

Cholangiocarcinoma Trial in Düsseldorf (Combination of Lonsurf® and Irinotecan)

Recruiting
  • Cholangiocarcinoma
  • Combination of Lonsurf® and Irinotecan
  • Düsseldorf, NRW, Germany
    Klinik für Gastroenterologie, Hepatologie und Infektiologie
Dec 22, 2022

Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

Active, not recruiting
Has Results
  • Advanced Bile Duct Carcinoma
  • +17 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 5, 2023

Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Germany (Irinotecan Liposomal Injection [Onivyde])

Active, not recruiting
  • Locally Advanced Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Irinotecan Liposomal Injection [Onivyde]
  • Amberg, Germany
  • +34 more
Aug 3, 2021

Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

Recruiting
  • Advanced Solid Tumors
  • +11 more
  • Boston, Massachusetts
  • +4 more
Dec 12, 2022

Toripalimab, Radiation Trial in Hangzhou (Toripalimab, CRT, SCRT)

Recruiting
  • Toripalimab
  • Radiation
  • Hangzhou, Zhejiang, China
    Zhengjiang Cancer Hospital
Dec 29, 2022

Metastatic Biliary Tract Cancer Trial in Seoul (Onivyde, 5-FU/LV)

Completed
  • Metastatic Biliary Tract Cancer
  • Seoul, Korea, Republic of
    Asan Medical Center
Aug 22, 2022

Liver Metastasis Colon Cancer Trial in Guangzhou (TACE and HAIC Combined With Regorafenib)

Not yet recruiting
  • Liver Metastasis Colon Cancer
  • TACE and HAIC Combined With Regorafenib
  • Guangzhou, Guangdong, China
    the first affiliated hospital, Sun-Yat sen university
Oct 2, 2023

Ewing's Sarcoma Trial in United States (Vigil, Temozolomide, Irinotecan)

Completed
Has Results
  • Ewing's Sarcoma
  • Vigil
  • +4 more
  • Little Rock, Arkansas
  • +5 more
Dec 20, 2022

Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7 Trial in United States (biological, drug, other)

Completed
Has Results
  • Colorectal Adenocarcinoma
  • +4 more
  • Bevacizumab
  • +4 more
  • Scottsdale, Arizona
  • +12 more
Jan 27, 2022

Colorectal Cancer, Metastatic Cancer Trial in Boulogne Billancourt (FOLFIRI regimen, fluorouracil, irinotecan HCl)

Withdrawn
  • Colorectal Cancer
  • Metastatic Cancer
  • FOLFIRI regimen
  • +7 more
  • Boulogne Billancourt, France
    Hopital Ambroise Pare
Aug 26, 2022

Metastatic Non Small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer Trial in Philadelphia (Etirinotecan pegol

Completed
Has Results
  • Metastatic Non Small Cell Lung Cancer
  • Recurrent Non Small Cell Lung Cancer
  • Etirinotecan pegol (NKTR-102)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 1, 2020

CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in

Active, not recruiting
Has Results
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Birmingham, Alabama
  • +23 more
Oct 7, 2022

Colorectal Cancer Trial in Pisa (Regorafenib, Panitumumab)

Recruiting
  • Colorectal Cancer
  • Pisa, PI, Italy
    U.O. Oncologia 2 Universitaria
Aug 3, 2022

Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors Trial in France (Sorafenib and irinotecan combination, Sorafenib

Completed
  • Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors
  • Sorafenib and irinotecan combination
  • +2 more
  • Bobigny, France
  • +8 more
Aug 20, 2019